Ganglioside Antibodies

Santa Cruz Biotechnology delivers a wide array of Ganglioside Antibodies for the detection and characterization of gangliosides, which are glycosphingolipids found in the outer membrane of cells. Ganglioside Antibodies are extensively used in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Gangliosides play essential roles in cell signaling, cell recognition, and the modulation of immune responses. Research has shown gangliosides are implicated in various neurological disorders and cancers, making their study vital for understanding disease mechanisms and developing therapeutic strategies. Advanced research in neuroscience and oncology continues to reveal new insights about ganglioside functions and their impact on cellular processes. Ganglioside research has opened new avenues for understanding membrane organization and cellular communication pathways. Scientists worldwide use ganglioside monoclonal antibodies to explore fundamental questions in cell biology and disease progression. Current investigations focus on how gangliosides influence neural development, tumor progression, and immune system regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to advance scientific understanding and develop innovative therapeutic approaches.